Insight

Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the EHA 2024 – Sylvester Comprehensive Cancer Center

Photo taken from Sylvester Comprehensive Cancer Center/X

Jun 17, 2024, 12:46

Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the EHA 2024 – Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center recently shared a post on X:

“Our very own Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the European Hematology Association Annual Meeting.

The trial shows that adults with blood cancers receiving mismatched peripheral blood stem cell transplants exhibited excellent survival rates and a low incidence of life-threatening graft-versus-host disease, safely expanding transplant access to patients of all races and ethnicities.”

Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the EHA 2024 - Sylvester Comprehensive Cancer Center

Source: Sylvester Comprehensive Cancer Center/X

access ACCESS trial Antonio Jimenez Jimenez blood cancers cancer EHA Annual Meeting EHA2024 European Hematology Association NMDP OncoDaily Oncology peripheral blood stem cell transplants Sylvester Comprehensive Cancer Center

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage